Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients

Details for Australian Patent Application No. 2004308166 (hide)

Owner Rappaport Family Institute for Research in the Medical Sciences

Inventors Levy, Andrew P.

Agent Griffith Hack

Pub. Number AU-A-2004308166

PCT Pub. Number WO2005/062706

Priority 10/748,177 31.12.03 US

Filing date 3 November 2004

Wipo publication date 14 July 2005

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/062706 Priority application(s): WO2005/062706

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308196-Food containing wheat germ obtained from wheat seed and process for producing the same

2004308157-An improved rotary sample collector